SCHEMBL4353771

SCHEMBL4353771

O=C(NCC1CCCCC1)N(S)c1cc(Cl)cc(Cl)c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.42
EPHX1 P07099 3/20 0.42
RAB9A P51151 2/20 0.42
EPHX2 P34913 1/20 0.42
GRM4 Q14833 1/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
HSD11B1 P28845 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
BCL2 P10415 1/20 0.38
BCL2L1 Q07817 1/20 0.38
MCL1 Q07820 1/20 0.38
BCL2A1 Q16548 1/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CNR1 P21554 1/20 0.38
MAPT P10636 2/20 0.37
MITF O75030 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4345583 0.85 GRM4 (0.39) NPC1EPHX1RAB9AEPHX2GRM4
SCHEMBL4351536 0.84 SMN1; SMN2 (0.41) NPC1EPHX1RAB9AEPHX2GRM4
SCHEMBL4342371 0.84 NPC1 (0.44) NPC1EPHX1RAB9AEPHX2GRM4
SCHEMBL4342279 0.83 EPHX1 (0.44) NPC1EPHX1RAB9AEPHX2MEN1
SCHEMBL4343408 0.83 EPHX1 (0.47) NPC1EPHX1RAB9AEPHX2MEN1
SCHEMBL4342426 0.82 NPC1 (0.40) NPC1EPHX1RAB9AEPHX2MEN1
SCHEMBL4354698 0.81 CYP2C19 (0.47) NPC1EPHX1RAB9AEPHX2MEN1
SCHEMBL4347205 0.77 MEN1 (0.43) NPC1EPHX1RAB9AMEN1KMT2A
SCHEMBL4347008 0.76 NPC1 (0.40) NPC1EPHX1RAB9AEPHX2SMN1; SMN2
SCHEMBL4348608 0.76 NPC1 (0.44) NPC1EPHX1RAB9AEPHX2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 NPC1 815/4885EPHX1 1676/4885RAB9A 4228/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 NPC1 1189/4885EPHX1 1334/4885RAB9A 4588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.